Article Text

PDF
FRI0020 BMP-2 and TGF-B Inhibit IL-34 Expression in Rheumatoid Arthritis Synovial Fibroblasts
  1. M. Chemel-Mary1,
  2. B. Legoff1,
  3. Y. Maugars1,
  4. D. Heymann1,
  5. F. Verrechia2
  1. 1Rheumatology, CHU Nantes
  2. 2INSERM U957, Université de Nantes, Nantes, France

Abstract

Background Interleukin-34 (IL-34) is a pro-osteoclastogenic cytokine, up-regulated by pro inflammatory cytokines, with a recently described role in rheumatoid arthritis (RA). TGF-b and BMP-2 are two members of the TGF-b family, whith an opposit role to the pro-inflammatory cytokines and that are also involved in rheumatoid synovitis.

Objectives The present study aimed to assess the IL-34 expression in response to two members of the TGF-b family, TGF-b1 and BMP-2, in synovial fibroblasts from RA patients.

Methods The IL-34, TGF-β1 and BMP-2 productions were measured in synovial fluids by ELISA. The IL-34 mRNA levels were quantified by qPCR in human synovial fibroblasts and murine mesenchymal stem cells (MSCs). Pharmacological inhibitions were used to determine the involvement of ALK1 and ALK5 downstream TGF-b1 and BMP-2.

Results IL-34, TGF-b1 and BMP-2 were expressed in synovial fluids from RA patients. We found a significant correlation between IL-34 and TGF-b1 expressions. Levels of both IL-34 and TGF-b1 were thus correlated with the total leukocyte counts in the synovial fluids. TGF-b1 and BMP-2 decreased Il-34 expression in the synovial fibroblasts or in mMSC in a dose/time dependent manner through respectively ALK5 and ALK1 pathways. In addition, TGF-b1 antagonized TNFa-induced IL-34 gene expression.

Conclusions This work identifies TGF-b1 and BMP-2 as potent inhibitors of IL-34 expression in RA synovial fibroblasts. These cytokines, as upstream inhibitors of IL-34, may thus contribute to antagonize inflammation and bone erosions in RA.

  1. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373:659–72.

  2. Lin H, Lee E, Hestir K, Leo C, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science. 2008;320:807–11.

  3. Baud'huin M, Renault R, Charrier C, et al. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 2010;221:77–86.

  4. Chemel M, Le Goff B, Brion R, et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis. 2012;71:150–4.

  5. Pohlers D, Beyer A, Koczan D, et al. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2007;9:R59.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.